Skip to main content

Eversept Partners, LP

SEC CIK
0001697013
Latest filing
Aug 14, 2026

GRCE holding history

Grace Therapeutics, Inc. in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GRCE overviewAll 13F holders of GRCEFull Q2 2026 holdings

Shares (Q2 2026)
772,900
Value
$1.75M
% of portfolio
0.1%
Quarters held
2
Since Q1 2026
Holdings of GRCE by Eversept Partners, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026772,900$1.75M0.1%+16,300+2.2%AddedHolders
Q1 2026756,600$3.50M0.2%+756,600NewHolders